Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells

A. D. Wickenden, A. Zou, P. K. Wagoner, T. Jegla

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Abstract

Heteromeric KCNQ5/Q3 channels were stably expressed in Chinese Hamster ovary cells and characterized using the whole cell voltage-clamp technique. KCNQ5/Q3 channels were activated by the novel anticonvulsant, retigabine (EC50 1.4 μM) by a mechanism that involved drug-induced, leftward shifts in the voltage-dependence of channel activation (-31.8 mV by 30 μM retigabine). KCNQ5/Q3 channels were inhibited by linopirdine (IC50 7.7 μM) and barium (IC50 0.46 mM), at concentrations similar to those required to inhibit native M-currents. These findings identify KCNQ5/Q3 channels as a molecular target for retigabine and raise the possibility that activation of KCNQ5/Q3 channels may be responsible for some of the anti-convulsant activity of this agent. Furthermore, the sensitivity of KCNQ5/Q3 channels to linopirdine supports the possibility that potassium channels comprised of KCNQ5 and KCNQ3 may make a contribution to native M-currents.

Original languageEnglish (US)
Pages (from-to)381-384
Number of pages4
JournalBritish Journal of Pharmacology
Volume132
Issue number2
DOIs
StatePublished - 2001

All Science Journal Classification (ASJC) codes

  • Pharmacology

Fingerprint Dive into the research topics of 'Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells'. Together they form a unique fingerprint.

Cite this